قالب وردپرس درنا توس
Home / SmartTech / Oviva Receives $ 21 Million in TechCrunch Digital Diabetes Treatment Prize

Oviva Receives $ 21 Million in TechCrunch Digital Diabetes Treatment Prize



Oviva, the health tech startup that offers a digital solution for the treatment of type 2 diabetes in Europe, raised $ 21 million in Series B funds.

Leading is MTIP, in which the new investor Earlybird and existing investors participate According to AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech.

Oviva will use the new capital to further develop its technology and further expand in Europe to care for more patients who currently have no access to treatment. This means that Oviva has reached a total of $ 34 million.

Oviva claims to have treated 90,000 patients in the UK, Germany, France, Switzerland and the United Arab Emirates in the past three years and offers an "evidence-based" digital solution for the progression of type 2 diabetes and disease in Stop and reverse obesity-related. According to the startup, patients receive tailored nutritional advice and personalized coaching over the phone, at lower costs and with better results than with personal therapy.

"With your consent, your doctor will send Oviva your diagnosis, relevant laboratory reports, background and contact details," explains Oviva co-founder and CEO Kai Eberhardt. “We will then contact you, either directly to ask you to download our app, or by phone to get you on board and initiate treatment. You will then be treated for four to nine months, depending on your health and local reimbursement. After that time, you can proceed, pay for yourself, or receive another referral (usually annually, as our behavioral change treatment is recommended in most guidelines every year and reimbursed each year). “

Eberhardt says that in most cases, the countries where Oviva is currently active, it is the patient's health insurance that pays for the service, and in the UK, the NHS pays access. "Typically, a prescription is required for patients who want to have access to our treatment," he says. "Most referrals are made by the patient's family doctor or, in some cases, specialists, such as an endocrinologist. A typical scenario is that the patient's doctor makes a referral when diagnosed or as part of a regular checkup to his chronic condition. "

Once Oviva was sent, the patient's" goal "was to lose weight, better control blood sugar, etc., and the patient was on board, they begin to record everything related is important with their lifestyle and illness. This includes photos of meals, activity, weight and symptoms. You can also connect a pedometer, a scale or a blood glucose meter to the app to automatically complete most of the data collection.

"You will agree certain behaviors with your nutritionist that you would like to change during treatment ( e.g. more vegetables and fruits, portion control, activity level), ”says Eberhardt. “Your nutritionist and a group of colleagues will help you achieve these goals. On the one hand, this is motivation and emotional support, on the other hand with specific information that is tailored to your needs, e.g. How to distribute meals and portion sizes throughout the day to avoid lows or periods of hunger. "

During treatment, a patient can also make video calls with their nutritionist and review a curriculum with videos and other content to help manage their condition as part of a" behavior change trip ".

Christoph Ruedig, partner at AlbionVC, says that despite convincing evidence that digital treatments improve patient access and outcomes while lowering health system costs, Europe is investing a fraction in digital health compared to the US " We look forward to continuing to support Oviva's accelerated adoption across Europe, "he says.
Source link